Skip to main content

Less-invasive surgery may not be best option for rectal cancer

7 October 2015
Concerns remain about the applicability of minimally invasive 'keyhole' surgery for rectal cancer.

More research needed to establish the case for routine use of laparoscopic surgery for rectal cancer.

A comparison of the surgical removal of rectal tumours by a laparoscopically-assisted 'keyhole' procedure and open surgery reveals that the case for routine use of laparoscopic procedures has not yet been established, according to a randomised control-trial study published today in The Journal of the American Medical Association.

The objective of the multicentre Australasian Laparoscopic Cancer of the Rectum Trial (ALaCaRT) involving 475 patients with T1-T3 rectal tumours was to assess whether laparoscopic surgery was similar – or no worse – than open surgery in terms of the successful removal of all the rectal cancer.

Ultimately the case for recommending the routine use of laparoscopic surgery for these patients will be based on long-term outcomes for recurrence and survival associated with each procedure.

Advances in laparoscopic technology since the 1990s have spurred the adoption of this operative approach to diseases of the rectum. Four international trials have reported that laparoscopic surgery is not worse than open surgery for colon cancer in terms of safety, length of hospital stay and survival, and some advantages in terms of morbidity.

However, concerns remain about the applicability of minimally invasive surgery for rectal cancer (the last 15 cm of the bowel, within the pelvis) following a randomised control trial comparison of laparoscopic vs conventional open surgery reporting that the laparoscopic group had a higher positive rate of involvement of the resection margin.

To this point, there has been little definitive evidence to guide surgeons about the safety and efficacy of laparoscopic versus open resection on pathological outcomes in rectal cancer. The ALaCaRT trial conducted by colorectal surgeons in Australia and New Zealand working with the Australasian Gastro-Intestinal Trials Group (AGITG), now reports some key findings on the rates of successful surgery and post-operative complications. This was based on surgical and tumour-related outcomes measures.

  • Successful resection was achieved in 82 per cent in the laparoscopic surgery group compared with 89 per cent in the open surgery group.
  • The circumferential resection margin was clear in 93 per cent of patients in the laparoscopic surgery group and 97 per cent of patients in the open surgery group.
  • The distal margin was clear in 99 per cent of patients in both groups.
  • A complete total mesorectal excision was achieved in 87 per cent of patients in the laparoscopic surgery group and 92 per cent of patients in the open surgery group.
  • 9 per cent of patients allocated to laparoscopic surgery had their operation converted to open surgery

The study’s lead investigator, Dr Andrew Stevenson said: “The ALaCaRT study is an important next step in analysing our approach to treating rectal cancer with laparoscopic surgery.

“The results of surgery performed by members of the Colorectal Surgical Society of Australia and New Zealand (CSSANZ) in this trial were excellent but we need to wait longer and get further results to understand the best way to use laparoscopic procedures, and to determine whether this is something suitable for all patients or considered with more caution in patients who are difficult to operate on.”

“The important clinical trial research the AGITG conducts in collaboration with the NHMRC Clinical Trials Centre at the University of Sydney is demonstrated by the results of the ALaCaRT trial which has just been published in The Journal of the American Medical Association,” said Associate Professor Tim Price, Chair of the Australasian Gastrointestinal Trials Group. “It is through collaborative efforts in clinical trial research that we will make a difference in the lives of people with gastro-intestinal cancer.”

Professor John Simes, Director of the NHMRC Clinical Trials Centre, University of Sydney, who oversaw the trial conduct said “This is an excellent example of ensuring patients will receive optimal care for their cancer based on a well conducted trial. It is a credit to the surgeons, clinical research team and particularly the patients who participated in the trial that we will be well placed to improve future practice.” 

Dan Gaffney

Media & PR Adviser (Medicine, Dentistry, Nursing and Pharmacy)
  • Room N302 Pharmacy A15

Related articles

23 June 2016

Australia 20 years after gun reform: no mass shootings, declining firearm deaths

Since major gun law reform 20 years ago, Australia has seen no mass shootings and an accelerating decline in intentional firearm deaths, the Journal of the American Medical Association reports today.

23 June 2016

New insights into the causes of sudden cardiac death in the young revealed

Sudden cardiac death claims the lives of 2-3 young Australians every week. 

28 June 2016

Are itchier insect bites more likely to make us sick?

New research suggests the worse our reactions to mosquito bites are, the more likely it is we’ll get sick, says Dr Cameron Webb.

15 June 2016

How can we make sense of the Orlando shooting?

As the world mourns the tragic loss of 50 lives, how can we answer the questions around homophobia and mental health raised by the Orlando shooting? Our researchers appeared on ABC’s The Drum to discuss the complex debate. 

13 December 2016

Confidence boost linked to weight loss in smartphone trial

Confidence is key when motivating young people to change their diet and exercise habits, new research from the University of Sydney shows.

13 December 2016

Sydney alum off to Stanford as Monash scholar

University of Sydney alumnus Dr Martin Seneviratne has been named the 2017 Roden Cutler NSW John Monash Scholar. The award will see Dr Seneviratne head to Stanford University to continue his ground-breaking work into clinical informatics.

14 December 2016

Brain structure best explains our dwindling tolerance of risk

Nature findings will improve understanding of decision-making, as global demographics shift toward an aged population. 

14 December 2016

Exotic mosquitoes a clear and present danger for Australians

Fears of outbreaks of Zika and dengue due to Australian travellers visiting affected countries this summer.

08 December 2016

Minister Ley launches Psychology clinics in Brain and Mind Centre

Federal Health and Aged Care Minister Sussan Ley today launched the one-stop-shop psychology, psychiatry and neuroscience clinics, touring the new facilities leading the way in multidisciplinary brain and mind care.

12 December 2016

Child mummy offers revised history of smallpox

A child mummy from the 17th century, found in a crypt underneath a Lithuanian church, was discovered to harbour the oldest known sample of the variola virus that causes smallpox.